The P2Y(12) antagonists, 2MeSAMP and cangrelor, inhibit platelet activation through P2Y(12)/G(i)-dependent mechanism.
about
Another "string to the bow" of PJ34, a potent poly(ADP-Ribose)polymerase inhibitor: an antiplatelet effect through P2Y12 antagonism?Racial differences in resistance to P2Y12 receptor antagonists in type 2 diabetic subjectsCangrelor: A Review in Percutaneous Coronary Intervention.Injury-induced purinergic signalling molecules upregulate pluripotency gene expression and mitotic activity of progenitor cells in the zebrafish retina.Selective inhibition of TRPM2 channel by two novel synthesized ADPR analogues.
P2860
The P2Y(12) antagonists, 2MeSAMP and cangrelor, inhibit platelet activation through P2Y(12)/G(i)-dependent mechanism.
description
2012 nî lūn-bûn
@nan
2012 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
The P2Y(12) antagonists, 2MeSA ...... (12)/G(i)-dependent mechanism.
@ast
The P2Y(12) antagonists, 2MeSA ...... (12)/G(i)-dependent mechanism.
@en
The P2Y(12) antagonists, 2MeSA ...... (12)/G(i)-dependent mechanism.
@nl
type
label
The P2Y(12) antagonists, 2MeSA ...... (12)/G(i)-dependent mechanism.
@ast
The P2Y(12) antagonists, 2MeSA ...... (12)/G(i)-dependent mechanism.
@en
The P2Y(12) antagonists, 2MeSA ...... (12)/G(i)-dependent mechanism.
@nl
prefLabel
The P2Y(12) antagonists, 2MeSA ...... (12)/G(i)-dependent mechanism.
@ast
The P2Y(12) antagonists, 2MeSA ...... (12)/G(i)-dependent mechanism.
@en
The P2Y(12) antagonists, 2MeSA ...... (12)/G(i)-dependent mechanism.
@nl
P2093
P2860
P1433
P1476
The P2Y(12) antagonists, 2MeSA ...... (12)/G(i)-dependent mechanism.
@en
P2093
Andrew J Morris
Binggang Xiang
Guoying Zhang
Hongmei Ren
Susan S Smyth
T Kent Gartner
P2860
P304
P356
10.1371/JOURNAL.PONE.0051037
P407
P577
2012-12-06T00:00:00Z